KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Goodwill (2021 - 2025)

Historic Goodwill for Fulgent Genetics (FLGT) over the last 5 years, with Q3 2025 value amounting to $25.1 million.

  • Fulgent Genetics' Goodwill rose 1371.57% to $25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.1 million, marking a year-over-year increase of 1371.57%. This contributed to the annual value of $22.1 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Goodwill is $25.1 million, which was up 1371.57% from $22.1 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Goodwill registered a high of $143.1 million during Q1 2023, and its lowest value of $22.1 million during Q4 2023.
  • For the 5-year period, Fulgent Genetics' Goodwill averaged around $63.5 million, with its median value being $36.9 million (2021).
  • Its Goodwill has fluctuated over the past 5 years, first surged by 42518.28% in 2022, then crashed by 8458.99% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Goodwill stood at $50.9 million in 2021, then skyrocketed by 137.68% to $121.0 million in 2022, then plummeted by 81.77% to $22.1 million in 2023, then changed by 0.0% to $22.1 million in 2024, then increased by 13.72% to $25.1 million in 2025.
  • Its last three reported values are $25.1 million in Q3 2025, $22.1 million for Q2 2025, and $22.1 million during Q1 2025.